LISATA THERAPEUTICS, INC. — Director's Dealing 2016

Aug 12, 2016

SEC Form 4/A — Form 4/A

Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-08-05

Reporting Person: LOSORDO DOUGLAS W (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-05	Common Stock	A	1000	—	Acquired	15397	Direct
2016-08-05	Common Stock	F	370	$6.25	Disposed	15027	Direct

Footnotes

F1: Includes 4,746 shares of unvested restricted stock.